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S U M M A R Y
Objectives: The objective of this study was to assess the association between lack of herd immunity in
some population groups and the re-emergence of measles in Catalonia in 2006.
Methods: Herd immunity was considered established in the different population groups when the
prevalence of positive serological results to measles was higher than the herd immunity threshold of
90%. The Chi-square test and the odds ratio were used to assess the association between lack of herd
immunity and measles cases in the outbreak of 2006–2007.
Results: Herd immunity was not established against measles in individuals aged 014 years and 2534
years, as the prevalence of positive serological results was <90% in these groups. In the measles outbreak
of 20062007, 91% of cases occurred in age groups without herd immunity, and only 9% of cases
occurred in age groups with herd immunity (p < 0.001). The odds ratio for the association between lack
of herd immunity and measles cases in the outbreak of 20062007 was 104 (p < 0.001).
Conclusion: Lack of herd immunity in individuals aged < 35 years could be one of the factors underlying
the re-emergence of measles in Catalonia.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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In 2010, the World Health Organization (WHO) European
Region renewed its commitment to the elimination of measles by
2015, but measles cases and outbreaks are still occurring in many
European countries.1–4 The highest ever reported incidence of
measles in the WHO European Region since measles surveillance
was implemented through the EUVAC.NET system, occurred in
2011.3,4 The EUVAC.NET surveillance system was established in
1999 for selected vaccine-preventable diseases.2 It incorporated all
European Union Member States together with Iceland, Norway,
Switzerland, and Turkey.
In Catalonia, an autonomous region of Spain with seven
million inhabitants, indigenous measles virus transmission was
interrupted in 2000, but a measles outbreak involving 381 cases
was declared in 2006.5 Analysis of the epidemiological char-
acteristics of the outbreak showed that 94% of cases occurred
among individuals aged <35 years, and 89% occurred among
unvaccinated individuals.5 The re-emergence of measles in     
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http://dx.doi.org/10.1016/j.ijid.2013.09.015Catalonia in 20062007 could be explained by the mobility of
people carrying measles infections from infected areas or
countries to Catalonia, and the lack of the necessary herd
immunity to block measles transmission in the population. The
herd immunity theory proposes that in diseases passed from
person-to-person, the chain of infection is blocked when the
prevalence of protected individuals in the population is higher
than a disease-speciﬁc threshold, known as the herd immunity
threshold (Ic).
6–9 The objective of this study was to assess the
association between lack of herd immunity in some population
groups and the re-emergence of measles in Catalonia in
20062007.
2. Methods
The association between lack of herd immunity and measles
cases in the outbreak of 20062007 was assessed by means of
comparing the distribution of measles cases in age groups with and
without herd immunity in 20062007 in Catalonia. The Chi-square
test and odds ratio (OR) were used to assess this association,
considering p < 0.05 as statistically signiﬁcant. The following age
groups were considered in the analysis: 0 months, 18 months,
914 months, 15 months4 years, 59 years, 1014 years, 1524
years, 2534 years, and 35 years.
Herd immunity was considered established in different
population groups in 20062007 when the prevalence of positiveociety for Infectious Diseases. Open access under CC BY-NC-SA license.
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prevalence of positive measles results associated with herd
immunity (pc): p > pc.
6–8 The value of pc was determined using
the formula pc = Ic Se + (1  Ic) (1  Sp), where Ic is the critical
prevalence of protected individuals blocking measles transmis-
sion,6,7 and Se (=97%) is the sensitivity and Sp (=97%) is the
speciﬁcity of the ELISA test used in the serological survey of 2002
(Measles ELISA Test, Wampole Laboratories, Cranbury, NJ, USA).6,7
The value of Ic was determined using the formula: Ic = 1  (1/Ro),
where Ro is the basic reproductive number. The value of Ro for
measles viruses ranges from 11 to 18.9
The prevalence of positive serological results in the different
age groups aged 5 years in 20062007 was determined using
SPSS v. 18 (SPSS Inc., Chicago, IL, USA) by taking into account
serological results obtained in the surveys of 2002 and the age
increase between 2002 and 2006. The seroepidemiological surveys
carried out in Catalonia in 2002 included a representative sample
of 1324 individuals aged 514 years, a representative sample of
1295 individuals aged 15 years, and a representative sample of
1498 neonates (0 months).6,7,10 Serological analysis for measles
was carried out in the Laboratory of Microbiology of the Hospital
Clinic of Barcelona. The presence of IgG measles antibodies was
determined using the measles IgG ELISA (Wampole Laboratories);
values >0.16 IU/ml were considered positive, values <0.12 IU/ml
were considered negative, and values between 0.12 and 0.16 IU/ml
were considered equivocal.6,7,10 Samples with equivocal results
were retested to conﬁrm the initial result. Samples nonreactive in
the second test were considered negative.
The prevalence of positive measles results in individuals aged
014 months and 15 months4 years in 2006 depended on
passive immunity and vaccine-induced immunity, respectively,
because the measles–mumps–rubella (MMR) vaccine was given at
15 months and 4 years.5,6 The prevalence of positive serological
results in neonates (0 months) in 2006 was determined assuming
that neonates in 2006 would not be different to those included in
the representative sample of neonates obtained in 2002.10
Consequently, the prevalence of positive serological results
(98.5%)10 observed in neonates in 2002 was assumed for neonatesTable 1
Prevalence (%) of positive serological results to measles in Catalonia in 2006, establishm
immunity and measles cases in the outbreak of 20062007
Age group Herd immunity levels in Catalonia in 2006 
Prevalence of positive serological results to
measles
% 95% CI n 
0 months 98.5 97.899.1 1498 
18 months 49.2 46.651.8 1498 
94 months 37.7 25.549.8 51 
15 months4 years 86.8 85.088.5 1498 
59 years 85.5 80.990.1 228 
1014 years 89.9 87.092.8 455 
1524 years 92.5 90.894.3 926 
2534 years 89.3 84.993.6 214 
35 years 98.3 97.599.2 1022 
Total No. of individuals in age-groups without herd immunity 
Total No. of individuals in age-groups with herd immunity 
OR (95% CI)
OR (95% CI) in individuals aged 5 years
OR, odds ratio; CI, conﬁdence interval.
a Herd immunity against measles was considered established (Pos) when the estima
prevalence associated with herd immunity (pc = 90%). The value of pc was determined 
protected individuals blocking measles transmission, Se (=97%) is the sensitivity, and Sp
ranges from 91% to 94% and pc ranges from 89% to 91% (mean 90%).
b p < 0.001.in 2006. The prevalence of positive serological results in
individuals aged 18 months in 2006 was determined assuming
that this prevalence would be 50% of the prevalence observed at 0
months, since maternal antibodies endure for a median of 3
months.11 The prevalence of positive serological results observed
in a sample of 51 infants aged 9–14 months (37.7%) studied in
Catalonia in 200712 was assumed for individuals aged 914
months in 2006.
The prevalence of positive measles results in individuals aged
15 months4 years, not included in the seroepidemiological
surveys of 2002, was determined using the formula
p = I Se + (1  I) (1  Sp), where I is the prevalence of protected
individuals due to vaccination in this age group in 2006.6 The value
of I in this age group was determined by multiplying the
vaccination coverage in individuals aged 1 year, 2 years, 3 years,
and 4 years in 200613 by the measles vaccine effectiveness,
adjusting the value of I for each year by the proportion of individuals
in the group: I = (I1 year 0.266) + (I2 years 0.252) + (I3 years 0.241) +
(I4 years  0.241) = (V1 year  E1 dose  0.266) + (V2 year  E1 dose 
0.252) + (V3 year  E1 dose  0.241) + (V4 year E2 doses 0.241).
Vaccine effectiveness of 92% was assumed for preventing secondary
cases of measles in individuals aged 13 years (1 dose) and 95% in
those aged 4 years (2 doses).14
3. Results
The estimated prevalences of positive serologic results to
measles in the different age groups in Catalonia in 2006 are
presented in Table 1. The estimated prevalence of positive measles
results in 2006 was higher than 92% only in individuals aged
1524 years and 35 years. The estimated prevalence of positive
measles results in individuals aged 15 months4 years was 86.8%.
This prevalence was obtained taking into account an MMR
vaccination coverage in 2006 of 96.8% in individuals aged 15
months, 97.3% in those aged 2 years, 96.7% in those aged 3 years,
and 96.7% for the ﬁrst dose and 94.1% for the second dose in those
aged 4 years.13ent of herd immunity in different age groups, and association between lack of herd
Distribution of
measles cases in the
outbreak of 20062007
Establishment of
herd immunity:a
Pos, prevalence >90%
Neg, prevalence <90%
No. %
Pos 0 0.0
Neg 28 7.4
Neg 148 38.8
Neg 80 21.0
Neg 13 3.4
Neg 10 2.6
Pos 10 2.6
Neg 68 17.9
Pos 24 6.3
347 91.1b
34 8.9
104.2 (63.4171.2)b
7.2 (4.112.5)b
ted prevalence of positive serological results (p) was higher than the mean critical
using the formula pc= Ic Se + (1  Ic) (1  Sp), where Ic is the critical prevalence of
 (=97%) is the speciﬁcity of the serological test. The value of Ic for measles viruses
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protected individuals (Ic) ranged from 91% to 94%. The herd
immunity threshold in terms of critical prevalence of positive
serological results to measles (pc) ranged from 89% to 91%, with a
mean value of 90%. Based on the critical prevalence of positive
measles results, herd immunity could not be established in 2006 in
individuals aged 035 years, except in those aged 1524 years,
while it could be established in individuals aged 35 years. The
analysis of the distribution of measles cases detected in the
outbreak of 20062007 showed that measles cases were more
frequent in age groups without herd immunity (91%) than in those
with herd immunity (9%), with statistically signiﬁcant differences
(p < 0.001) (Table 1). The OR for measles in age groups without
herd immunity was 104 (p < 0.001) (Table 1). The OR for measles
in age groups 5 years without herd immunity was 7.2 (p < 0.001).
4. Discussion
This study shows that lack of herd immunity in individuals aged
<35 years could be one of the factors underlying the re-emergence
of measles in Catalonia in 20062007, as most measles cases
occurred in age groups without herd immunity. In individuals aged
15 months–24 years, insufﬁcient herd immunity levels could be
explained by insufﬁcient vaccination coverage and/or insufﬁcient
vaccine effectiveness, while in those aged 25–34 years (unvacci-
nated),6 insufﬁcient herd immunity levels could be explained by a
lower circulation of measles viruses since 1981, when the measles
vaccination program was introduced in Catalonia.
The transmission of measles was interrupted in Catalonia in the
year 2000, and during the period 2000–2005, measles cases were
related to imported cases and no transmission chains involved
indigenous individuals.5 The measles outbreak of 2006–2007
occurred because one imported measles case infected population
groups without sufﬁcient herd immunity. Between 2000 and 2005,
measles transmission did not include indigenous individuals for one
of the following two reasons. First, imported measles cases did not
come into contact with indigenous population groups without herd
immunity. Second, the prevalence of indigenous and non-indige-
nous susceptible individuals aged <35 years could have been higher
in 2006 than in previous years due to waning vaccine-induced
immunity or lower vaccine effectiveness in the period 2000–2006.
The WHO European Region proposed eliminating measles by
2010, but the persistence of the disease in many European countries
made it impossible to achieve this objective.1 The elimination of
measles is a feasible objective for the following reasons: (1) humans
are the only reservoir for measles viruses; (2) effective vaccines are
available for measles; (3) highly sensitive and speciﬁc diagnostic
tests are available; and (4) efforts can be combined in order to
eliminate measles, mumps, and rubella.7 Nevertheless, the elimina-
tion of measles from Catalonia and Europe requires that a high
prevalence of protected individuals is achieved and maintained in
order to prevent outbreaks from imported cases.6–8
In the future, the number of adults susceptible to measles could
increase in Spain and other countries if the duration of vaccine-
induced immunity is lower than the duration of immunity from
natural infection. In this situation, serological surveillance systems
should be implemented in order to identify and immunize
population groups without herd immunity.7 Herd immunity could
be established in these groups by means of additional vaccinations.
Based on this preventive strategy, three complementary vaccina-
tion programs could be developed: (1) to vaccinate only
susceptible individuals identiﬁed using pre-vaccination screening
(‘catch-up of susceptibles’ strategy); (2) to vaccinate all individu-
als, regardless of their vaccination and disease status (‘catch-up’
strategy); and (3) to vaccinate individuals who have no documen-tation of completed vaccination, unless they have laboratory
evidence of immunity to measles, documentation of provider-
diagnosed measles, or a medical contraindication to the vaccine.7
The ‘catch-up of susceptibles’ strategy is the best complimentary
vaccination program for countries with high percentages of
vaccination coverage. The ‘catch-up’ strategy is the best preventive
strategy for countries with low percentages of vaccination
coverage and/or low vaccination effectiveness. The third strategy
can be developed only in countries with excellent vaccination
registries; however, the main problem of this preventive strategy is
that susceptible individuals due to primary vaccination failures
could be identiﬁed and immunized.
In conclusion, a lack of herd immunity could be one of the
factors explaining the re-emergence of measles in Catalonia
(Spain) in 2006. In Spain and other countries with high percentages
of measles vaccination coverage, serological surveillance systems
could be developed to detect population groups without herd
immunity, and additional vaccinations could be recommended in
these groups to prevent measles cases and outbreaks.
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